Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4,778Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Boehringer Ingelheim (Canada) Ltd.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Coatings Trends
Not Confirmed
arrow
Coatings Trends
Not Confirmed

NINTEDANIB ESILATE

Brand Name : OFEV

Patent Number : 2387013

Filing Date : 2000-10-09

Strength per Unit : 150 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2020-10-09

Date Granted : 2009-12-29

blank

02

arrow
Coatings Trends
Not Confirmed
arrow
Coatings Trends
Not Confirmed

NINTEDANIB ESILATE

Brand Name : OFEV

Patent Number : 2591083

Filing Date : 2005-12-21

Strength per Unit : 150 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-12-21

Date Granted : 2013-10-01

blank

03

arrow
Coatings Trends
Not Confirmed
arrow
Coatings Trends
Not Confirmed

NINTEDANIB ESILATE

Brand Name : OFEV

Patent Number : 2495350

Filing Date : 2003-08-11

Strength per Unit : 150 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2023-08-11

Date Granted : 2012-05-29

blank

04

arrow
Coatings Trends
Not Confirmed
arrow
Coatings Trends
Not Confirmed

NINTEDANIB ESILATE

Brand Name : OFEV

Patent Number : 2493310

Filing Date : 2003-07-18

Strength per Unit : 150 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2023-07-18

Date Granted : 2011-01-18

blank

05

arrow
Coatings Trends
Not Confirmed
arrow
Coatings Trends
Not Confirmed

NINTEDANIB ESILATE

Brand Name : OFEV

Patent Number : 2387013

Filing Date : 2000-10-09

Strength per Unit : 100 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2020-10-09

Date Granted : 2009-12-29

blank

06

arrow
Coatings Trends
Not Confirmed
arrow
Coatings Trends
Not Confirmed

NINTEDANIB ESILATE

Brand Name : OFEV

Patent Number : 2493310

Filing Date : 2003-07-18

Strength per Unit : 100 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2023-07-18

Date Granted : 2011-01-18

blank

07

arrow
Coatings Trends
Not Confirmed
arrow
Coatings Trends
Not Confirmed

NINTEDANIB ESILATE

Brand Name : OFEV

Patent Number : 2495350

Filing Date : 2003-08-11

Strength per Unit : 100 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2023-08-11

Date Granted : 2012-05-29

blank

08

arrow
Coatings Trends
Not Confirmed
arrow
Coatings Trends
Not Confirmed

NINTEDANIB ESILATE

Brand Name : OFEV

Patent Number : 2591083

Filing Date : 2005-12-21

Strength per Unit : 100 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-12-21

Date Granted : 2013-10-01

blank

09

Boehringer Ingelheim (Canada...

arrow
Coatings Trends
Not Confirmed

Boehringer Ingelheim (Canada) Ltd.

Country
arrow
Coatings Trends
Not Confirmed

NINTEDANIB ESILATE

Brand Name : OFEV

Patent Number : 2726267

Filing Date : 2009-06-04

Strength per Unit : 150 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-06-04

Date Granted : 2017-10-31

blank

10

Boehringer Ingelheim (Canada...

arrow
Coatings Trends
Not Confirmed

Boehringer Ingelheim (Canada) Ltd.

Country
arrow
Coatings Trends
Not Confirmed

NINTEDANIB ESILATE

Brand Name : OFEV

Patent Number : 2726267

Filing Date : 2009-06-04

Strength per Unit : 100 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-06-04

Date Granted : 2017-10-31

blank